Opportunity overview
Supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Roche Products Ltd
Matched by exact name
- Contract value
- £4.5m
- Awarded
- Not supplied
- Contract signed
- 30 Jan 2025
- Award ID
- 003218-2025-NP91221a-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Roche Products Ltd
Matched by exact name
- Contract value
- £27.1m
- Awarded
- Not supplied
- Contract signed
- 10 Mar 2021
- Award ID
- 004908-2021-NP91221(a)-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Roche Products Ltd
Matched by exact name
- Contract value
- £22.6m
- Awarded
- Not supplied
- Contract signed
- 21 Mar 2021
- Award ID
- 012233-2025-NP91221a-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Roche Products Ltd
Matched by exact name
- Contract value
- £27.2m
- Awarded
- Not supplied
- Contract signed
- 23 Mar 2021
- Award ID
- 016773-2021-NP91221(a)-1
- Status
- active
- Location
- Welwyn Garden City, UK, AL7 1TW, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
Lots
- This contract modification, effecting an extension of the Framework Agreement duration from 1 April 2025 until 31 March 2026, has been agreed between the supplier and the Authority on behalf of NHS Scotland to meet the additional demands of the Scottish Health and Social Care sector. This modification has been approved to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.Value not stated